Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?
Polis, Chelsea B., Achilles, Sharon L., Hel, Zdenek, Hapgood, Janet P.Language:
english
Journal:
Contraception
DOI:
10.1016/j.contraception.2017.12.003
Date:
December, 2017
File:
PDF, 273 KB
english, 2017